NORTH BETHESDA, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN, founded in 2016, is a micro nonprofit that reported $4K in total revenue in fiscal year 2024. Revenue fell 99% from the prior year — a significant decline worth monitoring. Expenses of $1.3M exceeded revenue, resulting in a 32083% operating deficit.
TO FUNCTION AS A NONPROFIT EDUCATIONAL, SCIENTIFIC AND RESEARCH ORGANIZATION TO ENABLE AND ADVANCE PEDIATRIC CLINICAL RESEARCH PRESCRIBED BY REGULATION THROUGH: (CONTINUED ON SCHED.O)
DURING THIS FIRST QUARTER OF 2025, THE ORGANIZATION RETURNED ANY PLEDGED FUNDS RECEIVED FROM MEMBERSHIP FEES AND EDUCATIONAL GRANTS.THE ORGANIZATION PROVIDES EXPERT GUIDANCE AND INPUT ON PEDIATRIC...
DURING THIS FIRST QUARTER OF 2025, THE ORGANIZATION RETURNED ANY PLEDGED FUNDS RECEIVED FROM MEMBERSHIP FEES AND EDUCATIONAL GRANTS.THE ORGANIZATION PROVIDES EXPERT GUIDANCE AND INPUT ON PEDIATRIC CLINICAL DEVELOPMENT PLANS AND PEDIATRIC CLINICAL TRIALS WITH THE GOAL OF IMPROVING THE PROCESSES AND ACCELERATING THE DEVELOPMENT OF INNOVATIVE PRODUCTS FOR USE IN CHILDREN. ADDITIONALLY, THE ORGANIZATION ALSO CONNECTS QUALIFIED CLINICAL TRIAL SITES IN OUR PEDIATRIC CLINICAL TRIAL SITE NETWORK WITH CLINICAL TRIALS FOR A VARIETY OF BIOPHARMACEUTICAL COMPANIES.THE ORGANIZATION UTILIZES ITS NETWORK OF EXPERTS TO CONVENE WORKING GROUPS TO TACKLE PROBLEMS IN PEDIATRIC CLINICAL DEVELOPMENT COMMON ACROSS A VARIETY OF STAKEHOLDERS, THAT OTHERWISE WOULD NOT BE ADDRESSED IN A PRECOMPETITIVE MANNER.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,060 | $648,518 | -1.0% |
| Expenses | $1,306,642 | $2,711,066 | -0.5% |
| Net Income | $-1,302,582 | $-2,062,548 | -0.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ELIZABETH GAROFALO | CHAIRWOMAN | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARTHA BRUMFIELD | SECRETARY/TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| BARRY BROOKS | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JAMES POMFRET | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| MAX COPPES | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JEFF BARRETT | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| DANIEL JORGENSEN | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| TAMAROH LEWIS | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| STEPHANIE DAVIS | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| KRISTEN SWINGLE | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| VIVIANNA GUZMAN | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$147,560 | $452 | $148,012 |
| ALBERT JOHN ALLEN | CMO (UNTIL 3/25) | 10.00 |
Officer
|
$22,568 | $2,554 | $25,122 |
| LAURA LOPEZ | CFAO | 40.00 |
Highest
|
$117,309 | $8,896 | $126,205 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,060 | $1,306,642 | No data | $-1,302,582 |
| 2024 | $648,518 | $2,711,066 | $1,381,300 | $-2,062,548 |
| 2023 | $1,463,891 | $3,296,795 | $3,501,048 | $-1,832,904 |
| 2022 | $3,274,066 | $5,107,870 | $5,456,460 | $-1,833,804 |
| 2021 | $5,280,418 | $6,202,128 | $7,633,622 | $-921,710 |
| 2020 | $7,129,650 | $5,234,764 | $8,517,224 | $1,894,886 |
| 2019 | $5,500,641 | $4,621,793 | $6,660,296 | $878,848 |
| 2018 | $2,086,510 | $2,560,182 | $4,378,274 | $-473,672 |
Compare INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN with other nonprofits in Maryland and across the country.